Original Development Brief – Requires creation of scientific integrity policies by federal agencies that fund or conduct scientific research, under the guidance of principles established by the Office of Science and Technology Policy.
Original Development Brief – Appropriates Federal Fiscal Year 2017 funding, and includes special provisions related to gene editing, precision medicine, Zika virus, opioids, mental health, and unmanned aerial vehicles.
Original Development Brief – Holds that a quantitative standard is used to determine whether "a substantial portion" of components of an invention has been supplied abroad in violation of section 271(f)(1) of the Patent Act.
Original Development Brief – Expands the ability of workplace wellness programs to collect personalized genetic information from employees but still remain in compliance with the Genetic Information Nondiscrimination Act, the American Disabilities Act, and the Public Health Service Act.
Seeks to advance the development of an adequate evidence base for genetic tests to improve patient care and treatment. Additionally, recommends a framework for decision-making regarding the use of genetic tests in clinical care.
Original Development Brief – Decides that The Regents of the University of California’s and The Broad Institute’s patents on CRISPR-Cas9 technology do not interfere with one another and are thus separately patentable.